These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 9620788)

  • 1. Nonpatentable drugs and the cost of our ignorance.
    Calon F
    CMAJ; 2006 Feb; 174(4):483-4. PubMed ID: 16477060
    [No Abstract]   [Full Text] [Related]  

  • 2. Research funders must join the fight for equal access to medicines.
    Nature; 2024 Feb; 626(7997):7-8. PubMed ID: 38291143
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH urged to cap profits made on publicly funded research.
    Macilwain C
    Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508
    [No Abstract]   [Full Text] [Related]  

  • 6. The Human Genome Project: a public good.
    Hudson K
    Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
    [No Abstract]   [Full Text] [Related]  

  • 7. New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.
    Antoñanzas F; Gómez P
    Pharmacoeconomics; 2010; 28(11):977-80. PubMed ID: 20936881
    [No Abstract]   [Full Text] [Related]  

  • 8. Bid to limit prices on drugs using 'public' discoveries.
    Wadman M
    Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
    [No Abstract]   [Full Text] [Related]  

  • 9. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical Research and Manufacturers of America v. Walsh: the Supreme Court allows the states to proceed with expanding access to drugs.
    Jost TS
    Yale J Health Policy Law Ethics; 2004; 4(1):69-84. PubMed ID: 15052860
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-on biologics: data exclusivity and the balance between innovation and competition.
    Grabowski H
    Nat Rev Drug Discov; 2008 Jun; 7(6):479-88. PubMed ID: 18469828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prescription for high drug prices.
    Pryor D
    Health Aff (Millwood); 1990; 9(3):101-9. PubMed ID: 2227770
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.